Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Glycosaminoglycan profiling in different cell types using infrared spectroscopy and imaging.

Brézillon S, Untereiner V, Lovergne L, Tadeo I, Noguera R, Maquart FX, Wegrowski Y, Sockalingum GD.

Anal Bioanal Chem. 2014 Jul 15. [Epub ahead of print]

PMID:
25023968
[PubMed - as supplied by publisher]
2.

Biotensegrity of the extracellular matrix: physiology, dynamic mechanical balance, and implications in oncology and mechanotherapy.

Tadeo I, Berbegall AP, Escudero LM, Alvaro T, Noguera R.

Front Oncol. 2014 Mar 4;4:39. doi: 10.3389/fonc.2014.00039. eCollection 2014. Review.

PMID:
24624363
[PubMed]
Free PMC Article
3.

TMA vessel segmentation based on color and morphological features: application to angiogenesis research.

Fernández-Carrobles MM, Tadeo I, Bueno G, Noguera R, Déniz O, Salido J, García-Rojo M.

ScientificWorldJournal. 2013 Dec 5;2013:263190. doi: 10.1155/2013/263190. eCollection 2013.

PMID:
24489494
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.

Rihani A, Van Maerken T, De Wilde B, Zeka F, Laureys G, Norga K, Tonini GP, Coco S, Versteeg R, Noguera R, Schulte JH, Eggert A, Stallings RL, Speleman F, Vandesompele J.

Pediatr Blood Cancer. 2014 Jan 4. doi: 10.1002/pbc.24927. [Epub ahead of print]

PMID:
24391119
[PubMed - as supplied by publisher]
5.

Quantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: a model in neuroblastoma.

Tadeo I, Piqueras M, Montaner D, Villamón E, Berbegall AP, Cañete A, Navarro S, Noguera R.

Pediatr Res. 2014 Feb;75(2):302-14. doi: 10.1038/pr.2013.217. Epub 2013 Nov 11.

PMID:
24216542
[PubMed - in process]
6.

snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.

von Stedingk K, Koster J, Piqueras M, Noguera R, Navarro S, Påhlman S, Versteeg R, Ora I, Gisselsson D, Lindgren D, Axelson H.

Transl Oncol. 2013 Aug 1;6(4):447-57. Print 2013 Aug.

PMID:
23908688
[PubMed]
Free PMC Article
7.

New prognostic markers in neuroblastoma.

Navarro S, Piqueras M, Villamón E, Yáñez Y, Balaguer J, Cañete A, Noguera R.

Expert Opin Med Diagn. 2012 Nov;6(6):555-67. doi: 10.1517/17530059.2012.704018. Epub 2012 Jul 11.

PMID:
23480837
[PubMed]
8.

Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion.

Villamón E, Berbegall AP, Piqueras M, Tadeo I, Castel V, Djos A, Martinsson T, Navarro S, Noguera R.

PLoS One. 2013;8(1):e53740. doi: 10.1371/journal.pone.0053740. Epub 2013 Jan 14.

PMID:
23341988
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Focal DNA copy number changes in neuroblastoma target MYCN regulated genes.

Kumps C, Fieuw A, Mestdagh P, Menten B, Lefever S, Pattyn F, De Brouwer S, Sante T, Schulte JH, Schramm A, Van Roy N, Van Maerken T, Noguera R, Combaret V, Devalck C, Westermann F, Laureys G, Eggert A, Vandesompele J, De Preter K, Speleman F.

PLoS One. 2013;8(1):e52321. doi: 10.1371/journal.pone.0052321. Epub 2013 Jan 4.

PMID:
23308108
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

NeuPAT: an intranet database supporting translational research in neuroblastic tumors.

Villamón E, Piqueras M, Meseguer J, Blanquer I, Berbegall AP, Tadeo I, Hernández V, Navarro S, Noguera R.

Comput Biol Med. 2013 Mar;43(3):219-28. doi: 10.1016/j.compbiomed.2012.11.011. Epub 2013 Jan 4.

PMID:
23290604
[PubMed - indexed for MEDLINE]
11.

Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome.

Schramm A, Schowe B, Fielitz K, Heilmann M, Martin M, Marschall T, Köster J, Vandesompele J, Vermeulen J, de Preter K, Koster J, Versteeg R, Noguera R, Speleman F, Rahmann S, Eggert A, Morik K, Schulte JH.

Br J Cancer. 2012 Oct 9;107(8):1409-17. doi: 10.1038/bjc.2012.391.

PMID:
23047593
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.

Decock A, Ongenaert M, Hoebeeck J, De Preter K, Van Peer G, Van Criekinge W, Ladenstein R, Schulte JH, Noguera R, Stallings RL, Van Damme A, Laureys G, Vermeulen J, Van Maerken T, Speleman F, Vandesompele J.

Genome Biol. 2012 Oct 3;13(10):R95. [Epub ahead of print]

PMID:
23034519
[PubMed - as supplied by publisher]
Free PMC Article
13.

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.

Schleiermacher G, Mosseri V, London WB, Maris JM, Brodeur GM, Attiyeh E, Haber M, Khan J, Nakagawara A, Speleman F, Noguera R, Tonini GP, Fischer M, Ambros I, Monclair T, Matthay KK, Ambros P, Cohn SL, Pearson AD.

Br J Cancer. 2012 Oct 9;107(8):1418-22. doi: 10.1038/bjc.2012.375. Epub 2012 Sep 13.

PMID:
22976801
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Extracellular matrix, biotensegrity and tumor microenvironment. An update and overview.

Noguera R, Nieto OA, Tadeo I, Fariñas F, Alvaro T.

Histol Histopathol. 2012 Jun;27(6):693-705. Review.

PMID:
22473691
[PubMed - indexed for MEDLINE]
15.

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

Schleiermacher G, Michon J, Ribeiro A, Pierron G, Mosseri V, Rubie H, Munzer C, Bénard J, Auger N, Combaret V, Janoueix-Lerosey I, Pearson A, Tweddle DA, Bown N, Gerrard M, Wheeler K, Noguera R, Villamon E, Cañete A, Castel V, Marques B, de Lacerda A, Tonini GP, Mazzocco K, Defferrari R, de Bernardi B, di Cataldo A, van Roy N, Brichard B, Ladenstein R, Ambros I, Ambros P, Beiske K, Delattre O, Couturier J.

Br J Cancer. 2011 Dec 6;105(12):1940-8. doi: 10.1038/bjc.2011.472. Epub 2011 Nov 10.

PMID:
22146831
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.

De Preter K, Mestdagh P, Vermeulen J, Zeka F, Naranjo A, Bray I, Castel V, Chen C, Drozynska E, Eggert A, Hogarty MD, Izycka-Swieszewska E, London WB, Noguera R, Piqueras M, Bryan K, Schowe B, van Sluis P, Molenaar JJ, Schramm A, Schulte JH, Stallings RL, Versteeg R, Laureys G, Van Roy N, Speleman F, Vandesompele J.

Clin Cancer Res. 2011 Dec 15;17(24):7684-92. doi: 10.1158/1078-0432.CCR-11-0610. Epub 2011 Oct 26.

PMID:
22031095
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Pleomorphic hyalinizing angiectatic tumor: a report of 3 new cases, 1 with sarcomatous myxofibrosarcoma component and another with unreported soft tissue palpebral location.

Illueca C, Machado I, Cruz J, Almenar S, Noguera R, Navarro S, Llombart-Bosch A.

Appl Immunohistochem Mol Morphol. 2012 Jan;20(1):96-101. doi: 10.1097/PAI.0b013e31821a24ab.

PMID:
22024990
[PubMed - indexed for MEDLINE]
18.

Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas.

Fieuw A, Kumps C, Schramm A, Pattyn F, Menten B, Antonacci F, Sudmant P, Schulte JH, Van Roy N, Vergult S, Buckley PG, De Paepe A, Noguera R, Versteeg R, Stallings R, Eggert A, Vandesompele J, De Preter K, Speleman F.

Int J Cancer. 2012 Jun 1;130(11):2599-606. doi: 10.1002/ijc.26317. Epub 2011 Aug 29.

PMID:
21796619
[PubMed - indexed for MEDLINE]
19.

Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.

Yáñez Y, Grau E, Oltra S, Cañete A, Martínez F, Orellana C, Noguera R, Palanca S, Castel V.

J Cancer Res Clin Oncol. 2011 Aug;137(8):1263-72. doi: 10.1007/s00432-011-0997-x. Epub 2011 Jun 25.

PMID:
21706131
[PubMed - indexed for MEDLINE]
20.

Prognostic value of partial genetic instability in neuroblastoma with ≤50% neuroblastic cell content.

Piqueras M, Navarro S, Cañete A, Castel V, Noguera R.

Histopathology. 2011 Jul;59(1):22-30. doi: 10.1111/j.1365-2559.2011.03899.x. Epub 2011 Jun 13.

PMID:
21668478
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk